D J Anderson

(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.

James P. Sullivan, Michael Decker, Jorge D. Brioni et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 168 citations

Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage

D J Anderson, JF Carnahan, Arie M. Michelsohn et al. · Journal of Neuroscience · 1991 · 141 citations · Full text

Cellular Neurobiology, Cellular Physiology, Peripheral Nervous System +25

Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.

Michael McKinney, D J Anderson, Carlos Forray et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 49 citations · Full text

Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.

John J. McGuire, D J Anderson, Brian M. Bennett · Journal of Pharmacology and Experimental Therapeutics · 1994 · 45 citations

Transmembrane orientation of an early biosynthetic form of acetylcholine receptor delta subunit determined by proteolytic dissection in conjunction with monoclonal antibodies

D J Anderson, Gerd A. Blobel, S J Tzartos et al. · Journal of Neuroscience · 1983 · 41 citations · Full text